Lung replacement therapies for acute respiratory failure

Acute respiratory failure is one of the criti-cal conditions with an increased mortality. In order to reverse lung injury and reduce the mortality rate, several lung replace-ment therapies have been developed, in-cluding the extracorporeal membrane oxygenation, the intravascular oxygenator and carbon dioxide removal device, the in-travenous membrane oxygenator and the thoracic artificial lung. This article aims to present the properties, indications and ad-vantages of these devices.

artificial organs, extracorporeal membrane oxygenation, respiratory insuf-ficiency

1. Suzuki T, Fukuda T, Ito T, Inoue Y, Cho Y, Kashima I. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg 2000;69(2):602-6.

2. Machin D, Allsager C. Principles of cardiopulmonary bypass. Contin Educ Anaesth Crit Care Pain 2006:6(5):176-81.

3. Friedman DF, Montenegro LM. Extracorporeal membrane oxygenation and cardiopulmonary bypass. In: Hillyer CD, Strauss RG, Luban NLC, eds. Handbook of Pediatric Transfusion Medicine. Amsterdam: Elsevier Inc. 2004;181-189. http://www.perfusione.net/Ecmo/DOC_ECMO/ECMO.pdf

4. Lewandowski K. Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 2000;4(3):156-68.

5. Reperfusion.com [homepage on the Internet]. West Columbia: Mid Carolina Internal Medicine Assoc.; 2004 [updated 19 Sep-tember 2016; cited 12 April 2016]. Available from: http://www.perfusion.com/cgi-bin/absolutenm/templates/articledisplay. asp?articleid=1807#.V-B0RGTmAd4

6. Gattinoni L, Kolobow T, Tomlinson T, Iapichino G, Samaja M, White D, et al. Low-frequency positive pressure ventilation with extra-corporeal carbon dioxide removal (LFPPV-ECCO2R): an experimental study. Anesth Analg 1978;57(4):470-7.

7. Gattinoni L, Pesenti A, Caspani ML, Pelizzola A, Mascheroni D, Marcolin R, et al. The role of total static lung compliance in the man-agement of severe ARDS unresponsive to conventional treatment. Intensive Care Med 1984;10(3):121-6.

8. Terragni PP, Del Sorbo L, Mascia L, Urbino R, Martin EL, Birocco A, et al. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 2009;111(4):826-35. doi: 10.1097/ALN.0b013e3181b764d2.

9. Bindslev L, Böhm C, Jolin A, Hambraeus Jonzon K, Olsson P, Ryniak S. Extracorporeal carbon dioxide removal performed with surface-heparinized equipment in patients with ARDS. Acta Anaesthesiol Scand Suppl 1991;95:125-30;130-1.

10. Conrad SA, Zwischenberger JB, Grier LR, Alpard SK, Bidani A. Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study. Intensive Care Med 2001 Aug;27(8):1340-51.

11. Hammainen P, Schersten H, Lemstrom K, Riise GC, Kukkonen S, Swärd K, et al. Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study. J Heart Lung Transplant 2011;30(1):103-7.

12. Hong X, Feng Z, Zhou G, Xu X. Extracorporeal membrane oxygenation as a support for TGA/IVS with low cardiac output syndrome and pulmonary hemorrhage. Rev Bras Cir Cardiovasc 2013;28(2):292-5.

13. Almond CS, Singh TP, Gauvreau K, Piercey GE, Fynn-Thompson F, Rycus PT, et al. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry. Circulation 2011;123(25):2975-84.

14. Chauhan S, Malik M, Malik V, Chauhan Y, Kiran U, Bisoi AK. Extra corporeal membrane oxygenation after pediatric cardiac surgery: a 10 year experience. Ann Card Anaesth 2011;14(1):19-24.

15. Finoti RG, Braile DM, Croti UA, Oliveira MA, Godoy MF, Leal JC, et al. Evaluation of infant membrane oxygenator in sheep. Rev Bras Cir Cardiovasc 2008;23(3):358-64.

16. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respira-tory failure: a multi-center database. Intensive Care Med 2009;35(12):2105-14.

17. Merrill ED, Schoeneberg L, Sandesara P, Molitor-Kirsch E, O’Brien J Jr, Dai H, et al. Outcomes after prolonged extracorporeal mem-brane oxygenation support in children with cardiac disease–Extracorporeal Life Support Organization registry study. J Thorac Car-diovasc Surg 2014;148(2):582-8.

18. Mortensen JD, Berry G. Conceptual and design features of a practical, clinically effective intravenous mechanical blood oxygen/carbon dioxide exchange device (IVOX). Int J Artif Organs 1989;12(6):384-9.

19. Gasche Y, Romand JA, Prêtre R, Suter PM. IVOX in ARDS: respiratory effects and serious complications. Eur Respir J 1994;7(4):821-3.

20. Cox CS Jr, Zwischenberger JB, Kurusz M. Development and current status of a new intracorporeal membrane oxygenator (IVOX). Perfusion 1991;6(4):291-6.

21. Sim KM, Evans TW, Keogh BF. Clinical strategies in intravascular gas exchange. Artif Organs 1996;20(7):807-10.

22. Intravascular nano-bubbling oxygenator [internet]. Taipei, TW; 2015 [cited 12 April 2016]. Available from: http://www.freshpatents. com/Intravascular-nano-bubbling-oxygenator-dt20090409ptan20090093751.php

23. Kanamori T, Niwa M, Kawakami H, Mori Y, Nagaoka S, Haraya K, et al. Estimate of gas transfer rates of an intravascular membrane oxygenator. ASAIO J 2000;46(5):612-9.

24. Shen L, Xie W, Pang YW, Zhong W, Du QG, Yang YL. Evaluation of oxygen transfer rate of intravenous membrane oxygenator mod-ules. J Fudan Univ (Nat Sci) 2003;42(6):979-82.

25. Hattler BG, Reeder GD, Sawzik PJ, Lund LW, Walters FR, Shah AS, et al. Development of an intravenous membrane oxygenator: en-hanced intravenous gas exchange through convective mixing of blood around hollow fiber membranes. Artif Organs 1994;18(11):806-12.

26. Federspiel WJ, Hout MS, Hewitt TJ, Lund LW, Heinrich SA, Litwak P, et al. Development of a low flow resistance intravenous oxygen-ator. ASAIO J 1997;43(5):M725-30.

27. Kim KH, Choi JB, Kim GB. Gas transfer of an implatable artificial lung. Biomed Eng Res 2014;3(3):74-9.

28. Zwischenberger JB, Alpard SK. Artificial lungs: a new inspiration. Perfusion. 2002;17(4):253-68.

29. Thoracic artificial lung design (A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philoso-phy (Biomedical Engineering) in the University of Michigan) [internet]. Michigan: University of Michigan; 2012 [cited 12 April 2016]. Available from: http://deepblue.lib.umich.edu/handle/2027.42/94005

30. Cook KE, Perlman CE, Seipelt R, Backer CL, Mavroudis C, Mockrost LF. Hemodynamic and gas transfer properties of a compliant thoracic artificial lung. ASAIO J 2005;51(4):404-11.

31. Cook KE, Makarewicz AJ, Backer CL, Mockros LF, Przybylo HJ, Crawford SE, et al. Testing of an intrathoracic artificial lung in a pig model. ASAIO J 1996;42(5):M604-9.

32. Sato H, Griffith GW, Hall CM, Toomasian JM, Hirschl RB, Bartlett RH, et al. Seven-day artificial lung testing in an in-parallel configu-ration. Ann Thorac Surg 2007;84(3):988-94.

33. Eash HJ, Jones HM, Hattler BG, Federspiel WJ. Evaluation of plasma resistant hollow fiber membranes for artificial lungs. ASAIO J 2004;50(5):491-7.

34. Zhu A, Zhang J, Shen J. Preparation and anticoagulant property of phosphorylcholine‐terminated o‐benzoylchitosan derivative. J Appl Polymer Sci 2003;88(2):489-93.